A rating of 85 puts Kura Oncology Inc (KURA) near the top of the Biotechnology industry according to InvestorsObserver. Kura Oncology Inc's score of 85 means it scores higher than 85% of stocks in the industry. Kura Oncology Inc also received an overall rating of 51, putting it above 51% of all stocks. Biotechnology is ranked 109 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 51 means the stock is more attractive than 51 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Kura Oncology Inc Stock Today?
Kura Oncology Inc (KURA) stock is higher by 2.03% while the S&P 500 is lower by -0.25% as of 11:34 AM on Monday, Jun 14. KURA is higher by $0.45 from the previous closing price of $22.42 on volume of 234,765 shares. Over the past year the S&P 500 is up 38.16% while KURA is higher by 35.33%. KURA lost -$1.73 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Kura Oncology Inc (KURA) Stock.
